Mechanisms of transport and structure-permeability relationship of sulfasalazine and its analogs in Caco-2 cell monolayers
- PMID: 11145220
- DOI: 10.1023/a:1026450326712
Mechanisms of transport and structure-permeability relationship of sulfasalazine and its analogs in Caco-2 cell monolayers
Abstract
Purpose: To investigate the mechanisms involved in transport of sulfasalazine in Caco-2 cells.
Methods: Permeability coefficients of sulfasalazine and its analogs across Caco-2 cell monolayers were measured as a function of direction of transport, energy and concentration dependence, and in the presence of inhibitors of various cellular efflux pumps and transporters.
Results: Permeability coefficients of sulfasalazine across Caco-2 cell monolayers were approximately 342-, 261-, and 176-fold higher from basolateral to apical direction (BL-->AP) than from apical to basolateral direction (AP-->BL) at 100, 200, and 500 microM, respectively. Carrier permeability coefficient, non-saturable membrane permeability coefficient, and Michaelis constant were estimated to be 1.4x10(-5) cm/s, 1.9x10(-8) cm/s, and 369 microM, respectively. The efflux of sulfasalazine was completely blocked at 4 degrees C and in the presence of an uncoupler of oxidative phosphorylation. Using cellular efflux inhibitors, the permeability of sulfasalazine was shown to depend on multidrug resistance-associated protein and anion sensitive transport mechanisms. Structure-permeability studies showed that the affinity of sulfasalazine for the cellular efflux pumps and transporters in Caco-2 cells depended strongly on the carboxylic acid functional group.
Conclusions: The permeability of sulfasalazine across Caco-2 cell monolayer is very low due to its strong interaction with multiple cellular efflux pumps and transporters. This may partially explain its low absorption in vivo.
Similar articles
-
Small intestinal efflux mediated by MRP2 and BCRP shifts sulfasalazine intestinal permeability from high to low, enabling its colonic targeting.Am J Physiol Gastrointest Liver Physiol. 2009 Aug;297(2):G371-7. doi: 10.1152/ajpgi.00102.2009. Epub 2009 Jun 18. Am J Physiol Gastrointest Liver Physiol. 2009. PMID: 19541926
-
MRP2 mediated drug-drug interaction: indomethacin increases sulfasalazine absorption in the small intestine, potentially decreasing its colonic targeting.Int J Pharm. 2010 Feb 15;386(1-2):216-20. doi: 10.1016/j.ijpharm.2009.11.021. Epub 2009 Nov 26. Int J Pharm. 2010. PMID: 19944137
-
The H2 receptor antagonist nizatidine is a P-glycoprotein substrate: characterization of its intestinal epithelial cell efflux transport.AAPS J. 2009 Jun;11(2):205-13. doi: 10.1208/s12248-009-9092-5. Epub 2009 Mar 25. AAPS J. 2009. PMID: 19319690 Free PMC article.
-
Interaction of ochratoxin A with human intestinal Caco-2 cells: possible implication of a multidrug resistance-associated protein (MRP2).Toxicol Lett. 2003 Apr 11;140-141:465-76. doi: 10.1016/s0378-4274(03)00043-2. Toxicol Lett. 2003. PMID: 12676495 Review.
-
Increasing the throughput and productivity of Caco-2 cell permeability assays using liquid chromatography-mass spectrometry: application to resveratrol absorption and metabolism.Comb Chem High Throughput Screen. 2003 Dec;6(8):757-67. doi: 10.2174/138620703771826865. Comb Chem High Throughput Screen. 2003. PMID: 14683481 Review.
Cited by
-
Prediction of the permeability of neutral drugs inferred from their solvation properties.Bioinformatics. 2016 Apr 15;32(8):1163-9. doi: 10.1093/bioinformatics/btv725. Epub 2015 Dec 10. Bioinformatics. 2016. PMID: 26656568 Free PMC article.
-
The "high solubility" definition of the current FDA Guidance on Biopharmaceutical Classification System may be too strict for acidic drugs.Pharm Res. 2004 Feb;21(2):293-9. doi: 10.1023/b:pham.0000016242.48642.71. Pharm Res. 2004. PMID: 15032311
-
Mechanisms responsible for poor oral bioavailability of paeoniflorin: Role of intestinal disposition and interactions with sinomenine.Pharm Res. 2006 Dec;23(12):2768-80. doi: 10.1007/s11095-006-9100-8. Epub 2006 Oct 25. Pharm Res. 2006. PMID: 17063398
-
Study on the mechanism of intestinal absorption of epimedins a, B and C in the Caco-2 cell model.Molecules. 2014 Jan 7;19(1):686-98. doi: 10.3390/molecules19010686. Molecules. 2014. PMID: 24402200 Free PMC article.
-
Transport studies with 5-aminosalicylate.Eur J Clin Pharmacol. 2006 Oct;62(10):871-5. doi: 10.1007/s00228-006-0182-3. Epub 2006 Aug 30. Eur J Clin Pharmacol. 2006. PMID: 16944117
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources